US Stock MarketDetailed Quotes
APLS Apellis Pharmaceuticals
- 33.190
- +0.450+1.37%
Close Dec 13 16:00 ET
- 33.190
- 0.0000.00%
Post 20:01 ET
4.13BMarket Cap-16.35P/E (TTM)
33.500High31.760Low5.51MVolume32.600Open32.740Pre Close182.12MTurnover6.53%Turnover RatioLossP/E (Static)124.39MShares73.80052wk High17.41P/B2.80BFloat Cap24.34052wk Low--Dividend TTM84.36MShs Float94.750Historical High--Div YieldTTM5.32%Amplitude11.450Historical Low33.071Avg Price1Lot Size
Apellis Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 78.29%196.83M | 110.26%199.69M | 284.26%172.33M | 425.83%396.59M | 545.89%146.38M | 400.54%110.4M | 481.85%94.97M | 211.84%44.85M | 13.31%75.42M | -62.41%22.66M |
| Operating revenue | 78.29%196.83M | 110.26%199.69M | 284.26%172.33M | 425.83%396.59M | 545.89%146.38M | 400.54%110.4M | 481.85%94.97M | 211.84%44.85M | 13.31%75.42M | -62.41%22.66M |
| Cost of revenue | 49.74%33.56M | 175.69%23.1M | 158.79%20.21M | 938.15%58.51M | 580.75%19.91M | 1,522.74%22.41M | 10,118.29%8.38M | 526.22%7.81M | 8.38%5.64M | -42.09%2.93M |
| Gross profit | 85.56%163.27M | 103.93%176.59M | 310.71%152.12M | 384.45%338.08M | 540.72%126.47M | 325.58%87.99M | 433.19%86.59M | 181.99%37.04M | 13.73%69.79M | -64.27%19.74M |
| Operating expense | -6.45%210.55M | -0.48%206.03M | 0.98%214.21M | 28.72%855.2M | 14.80%210.98M | 29.64%225.07M | 25.58%207.03M | 49.24%212.12M | 11.17%664.4M | 27.07%183.79M |
| Selling and administrative expenses | -16.25%121.98M | 15.00%128.08M | 26.85%129.51M | 80.69%500.82M | 67.96%141.7M | 85.76%145.65M | 76.21%111.37M | 99.45%102.09M | 56.79%277.16M | 103.48%84.37M |
| -General and administrative expense | ---- | ---- | ---- | 80.69%500.82M | ---- | ---- | ---- | ---- | 56.79%277.16M | 103.48%84.37M |
| Research and development costs | 11.52%88.57M | -18.51%77.95M | -23.02%84.7M | -8.48%354.39M | -30.32%69.28M | -16.58%79.42M | -5.90%95.66M | 20.98%110.03M | -7.99%387.24M | -3.64%99.42M |
| Operating profit | 65.51%-47.28M | 75.55%-29.44M | 64.54%-62.09M | 13.03%-517.12M | 48.48%-84.52M | 10.37%-137.08M | 18.96%-120.44M | -35.73%-175.08M | -10.88%-594.61M | -83.50%-164.05M |
| Net non-operating interest income expense | -315.47%-9.64M | -361.17%-6.18M | -71.54%-3.66M | 63.53%-8.65M | 9.77%-2.85M | 54.44%-2.32M | 80.92%-1.34M | 74.69%-2.14M | -84.92%-23.71M | -6.11%-3.16M |
| Non-operating interest income | -42.09%2.89M | -46.95%3.18M | -38.75%3.3M | 134.83%20.93M | -0.59%4.55M | 77.61%4.99M | 319.13%6M | 5,403.06%5.39M | 2,032.54%8.91M | 12,264.86%4.58M |
| Non-operating interest expense | 71.44%12.53M | 27.49%9.36M | -7.46%6.97M | -9.33%29.58M | -4.34%7.4M | -7.50%7.31M | -13.10%7.34M | -11.82%7.53M | 146.40%32.63M | 156.39%7.74M |
| Other net income (expense) | 111.61%70K | -2,955.56%-1.93M | -80.14%-499K | 97.81%-727K | 189.02%219K | 98.16%-603K | -142.28%-63K | 4.15%-277K | 83.15%-33.18M | 99.55%-246K |
| Special income (charges) | --0 | ---1.95M | ---- | --0 | --0 | --0 | --0 | ---- | 67.30%-32.89M | --0 |
| -Less:Other special charges | ---- | --1.95M | ---- | ---- | ---- | ---- | ---- | ---- | -67.30%32.89M | --0 |
| Other non- operating income (expenses) | 111.61%70K | 138.10%24K | -80.14%-499K | -152.43%-727K | 189.02%219K | -709.09%-603K | -142.28%-63K | 4.15%-277K | -121.15%-288K | -6,050.00%-246K |
| Income before tax | 59.39%-56.85M | 69.19%-37.54M | 62.67%-66.25M | 19.19%-526.5M | 47.96%-87.15M | 26.63%-140M | 21.64%-121.84M | -28.88%-177.5M | 12.67%-651.5M | -13.47%-167.46M |
| Income tax | 154.08%592K | -41.24%114K | -39.72%170K | 218.68%2.13M | 196.74%1.42M | -47.76%233K | -60.08%194K | -76.66%282K | 90.06%669K | -517.90%-1.47M |
| Net income | 59.04%-57.45M | 69.14%-37.66M | 62.64%-66.42M | 18.94%-528.63M | 46.64%-88.58M | 26.68%-140.24M | 21.76%-122.04M | -27.96%-177.78M | 12.62%-652.17M | -12.21%-165.99M |
| Net income continuous Operations | 59.04%-57.45M | 69.14%-37.66M | 62.64%-66.42M | 18.94%-528.63M | 46.64%-88.58M | 26.68%-140.24M | 21.76%-122.04M | -27.96%-177.78M | 12.62%-652.17M | -12.21%-165.99M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 59.04%-57.45M | 69.14%-37.66M | 62.64%-66.42M | 18.94%-528.63M | 46.64%-88.58M | 26.68%-140.24M | 21.76%-122.04M | -27.96%-177.78M | 12.62%-652.17M | -12.21%-165.99M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 59.04%-57.45M | 69.14%-37.66M | 62.64%-66.42M | 18.94%-528.63M | 46.64%-88.58M | 26.68%-140.24M | 21.76%-122.04M | -27.96%-177.78M | 12.62%-652.17M | -12.21%-165.99M |
| Basic earnings per share | 60.68%-0.46 | 70.59%-0.3 | 65.38%-0.54 | 27.64%-4.45 | 51.33%-0.73 | 33.14%-1.17 | 30.14%-1.02 | -9.86%-1.56 | 30.43%-6.15 | 1.96%-1.5 |
| Diluted earnings per share | 60.68%-0.46 | 70.59%-0.3 | 65.38%-0.54 | 27.64%-4.45 | 51.33%-0.73 | 33.14%-1.17 | 30.14%-1.02 | -9.86%-1.56 | 30.43%-6.15 | 1.96%-1.5 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
